Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for amphotericin root_Display\ Name in Display Name (approximate match)

Showing 1751 - 1760 of 1936 results

First page
Previous page
Next page
Next page

PM-HAdV3 (Pool of 234 peptides derived from a peptide scan (15mers with 11 aa overlap) through Hexon protein of Human Adenovirus (HAdV) - type B serotype 3)

J4MA6E23JR

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

HAdV-5 (penton protein) Pool of 140 peptides derived from a peptide scan (15mers with 11 aa overlap) through Penton protein of Human Adenovirus (HAdV) - type B serotype 5.

MH8T3997YU

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B

HZJ2V81RYU

Status:

Possibly Marketed Outside US

Source:

ANDA075679

(2003)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=198a4140-f4c0-4478-9157-ee1d68d0bb96

First approved in 2003

Source:

ANDA075679

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=198a4140-f4c0-4478-9157-ee1d68d0bb96

Class:

G1 SPECIFIED SUBSTANCE

NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN

91523M4S24

Status:

US Approved Rx (2014)

Source:

BLA125549

(2014)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2014

Source:

BLA125549

Source URL:

https://www.fda.gov/media/113210/download

Class:

CONCEPT

NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN

28E911Y7AE

Status:

US Approved Rx (2014)

Source:

BLA125549

(2014)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2014

Source:

BLA125549

Source URL:

https://www.fda.gov/media/113210/download

Class:

CONCEPT

NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN

25DB599G64

Status:

US Approved Rx (2014)

Source:

BLA125549

(2014)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2014

Source:

BLA125549

Source URL:

https://www.fda.gov/media/113210/download

Class:

CONCEPT

NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN

1S25R442RS

Status:

US Approved Rx (2015)

Source:

BLA125546

(2015)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2014

Source:

BLA125549

Source URL:

https://www.fda.gov/media/113210/download

Class:

CONCEPT

HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN

LUY6P8763W

Status:

US Approved Rx (1989)

Source:

BLA103237

(1989)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1989

Source:

BLA103237

Source URL:

https://www.fda.gov/media/113210/download

Class:

CONCEPT

(2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-methoxy-7,9-dioxo-2,5-methanopyrido[1?,2?:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid

RD7MNM79RD

Status:

Other

Class:

CONCEPT

2,5-Methanopyrido[1?,2?:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid, 2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-, (2R,5S,13aR)-

699ER2QJ9D

Status:

Other

Class:

CONCEPT

J4MA6E23JR
Not a public record

Concept

PM-HAdV3 (Pool of 234 peptides derived from a peptide scan (15mers with 11 aa overlap) through Hexon protein of Human Adenovirus (HAdV) - type B serotype 3)

Concept

HAdV-5 (penton protein) Pool of 140 peptides derived from a peptide scan (15mers with 11 aa overlap) through Penton protein of Human Adenovirus (HAdV) - type B serotype 5.

HZJ2V81RYU
Not a public record

Concept

ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B

Concept

NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN

Concept

NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN

Concept

NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN

Concept

NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN

Concept

HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN

Concept

(2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-methoxy-7,9-dioxo-2,5-methanopyrido[1?,2?:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid

Concept

2,5-Methanopyrido[1?,2?:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid, 2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-, (2R,5S,13aR)-

Showing 1751 - 1760 of 1936 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1